Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma

Blood

Volumn 89, Issue 12, 1997, Pages 4514-4520

  Melnyk, A ^a   Rodriguez, A ^a   Pugh, W C ^a   Cabannillas, F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER SURVIVAL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SEZARY CELL; T LYMPHOCYTE ACTIVATION;

EID: 0030980302     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4514     Document Type: Article

References (28)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
2. Coiffier B, Brouse N, Peuchmaur M, Berger F, Gisselbrecht C, Byron PA, Diebold J, for the GELA: Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1:45, 1990
3. Grogan TM, Fiedler K, Rangel C, Jolley CJ, Wirt DP, Hicks MJ, Miller TP, Brooks R, Greeenberg B, Jones S: Peripheral T-cell lymphoma: Aggressive disease with heterogenous immunotypes. Am J Clin Pathol 83:279, 1984
4. Noorduyn LA, Van der Valk P, Van Heerde P, Vroom TM, Blok P, Willemze R, Meijer CJL: Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma. Am J Clin Pathol 93:49. 1990
5. Kwak LW, Wilson M, Weiss LM, Doggett R, Dorfman RF, Warnke RA, Horning S: Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experience. J Clin Oncol 9:1426, 1991
6. Rodriguez J, Pugh WC, Cabanillas F: T-cell rich B-cell lymphoma. Blood 82:1586, 1993
7. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
8. Weis JW, Winter MW, Phyliky RL, Banks PM: Peripheral T-cell lymphomas: Histologic, immunohistologic, and clinical characterization. Mayo Clin Proc 61:411, 1986
9. Armitage JO, Greer JP, Levine AM, Weisenburger DD, Formenti SC, Bast M, Conley S, Pierson J, Linder J, Cousar JB, Nathwani BN: Peripheral T-cell lymphoma. Cancer 63:158, 1989
10. Chott A, Augustin I, Wrba F, Hanak H, Ohlinger W, Radaszkiewicz T: Peripheral T-cell lymphomas: A clinicopathologic study of 75 cases. Hum Pathol 21:1117, 1990
11. Lippman SM, Miller TP, Speir CM, Slyman DJ, Grogan TM: The prognostic significance of the immunophenotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype. Blood 72:436, 1988
12. Montalban C, Obeso G, Gallego A, Castrillo JM, Bellas C, Rivas C: Peripheral T-cell lymphoma: A clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification. Histopathology 22:303, 1993
13. Pinkus G, O'Hara CJ, Said JW: Peripheral/post-thymic T-cell lymphomas: A spectrum of disease. Cancer 65:971, 1990
14. Greer JP, York JC, Cousar JB, Mitchel RT, Flexner JM, Collins RD, Stein RS: Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. J Clin Oncol 2:788, 1984
15. Su I, Wang C, Cheng A, Chen Y, Hsieh H, Chen C, Tien H, Woei-tsay, Huang S, Hu C, Chen P, Chen J, Hsu H, Chuang S, Shen M, Kadin ME: Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. Cancer 61:2060, 1988
16. Brisbane JU, Berman LD, Neiman RS: Peripheral T-cell lymphoma: A clinicopathologic study of nine cases. Am J Clin Pathol 79:285, 1983
17. Weisenburger DD, Astorino RN, Glassy FJ, Miller CH, MacKenzie MR, Gaggiano V: Peripheral T-cell lymphoma: A clinicopathologic study of a morphologically diverse entity. Cancer 56:2061, 1985
18. Cossman J, Jaffe ES, Fisher RI: Immunologic phenotypes of diffuse, aggressive, non-Hodgkin's lymphoma: Correlation with clinical features. Cancer 54:1310, 1983
19. Jagannath S, Velasquez WS, Tucker SL, Fuller LM, McLaughlin PW, Manning JT, North LB, Cabanillas F: Tumor burden assessment and its implication for a prognostic model in advanced diffuse large cell lymphoma. J Clin Oncol 4:859, 1986
20. Rodriguez J, Cabanillas F, McLaughlin P, Swan F, Rodriguez M, Hagemeister F, Romaguera J: A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the "tumor score." Ann Oncol 3:711, 1992
21. Swan F, Velasquez WS, Fuller L, Rodriguez A, McLaughlin P, Romaguera J, Redman J, Hagemeister F, Cabanillas F: Successful outcome of patients with good risk large cell lymphoma with a shortened schedule of treatment. Proc Am Soc Clin Oncol 10:272, 1991 (abstr 947)
22. Cabanillas F, Velasquez WS, McLaughlin P, Jagganath S, Hagemeister FB, Redman JR, Swan F, Rodrigueq M: Results of recent salvage chemotherapy regimens for non-Hodgkin's lymphoma and Hodgkin's disease. Semin Hematol 25:47, 1988 (suppl 2)
23. Horning SJ, Weiss LM, Crabtree GS, Warnke RA: Clinical and phenotypic diversity of T cell lymphomas. Blood 67:1578, 1986
24. Hastrup N, Hamilton-Dutoit S, Ralfkiaer E, Pallesen G: Peripheral T-cell lymphomas: An evaluation of reproducibility of the updated Kiel classification. Histopathology 18:99, 1991
25. Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES: Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T-cell proliferations. Blood 72:1674, 1988
26. + (ALCL): Clinical features and long-term response in 40 consecutive patients. Blood 84:165a, 1994 (abstr, suppl 1)
27. Frizzera G, Kaneko Y, Sakurai M: Angioimmunoblastic lymphadenopathy and related disorders: A retrospective look in search of definitions. Leukemia 3:1, 1989
28. Vose JM, Peterson C, Bierman PJ, Weisenberger DD, Linder J, Harrington D, Vaughan WP, Kessinger A, Armitage JO: Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas. Blood 76:424, 1990